Related Experiment Video
Updated: Jul 5, 2025
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Diazepam-based covalent modifiers of GPX4 induce ferroptosis in liver cancer cells
Dharmendra K Yadav1, Sona Tiwari1, Sathyapriya Senthil1
1Department of Chemistry, Indian Institute of Technology Kanpur, Uttar Pradesh-208016, India. atdharma@iitk.ac.in.
Abstract:
Developing new chemotherapeutics that are structurally and mechanistically unique is needed due to the rapid rise of the cancer incidence across the globe. Here, we report the identification of irreversible, thiol-reactive diazepam derivatives as GPX4 modifiers and nanomolar inducers of ferroptosis in liver cancer cells.
Insights
New chemotherapy drugs are essential for fighting cancer. Researchers identified unique diazepam derivatives that trigger cell death (ferroptosis) in liver cancer by targeting GPX4.
Area of Science:
- Medicinal Chemistry
- Oncology
- Cell Biology
Background:
- The global rise in cancer incidence necessitates novel chemotherapeutics with unique structures and mechanisms.
- Targeting specific cell death pathways like ferroptosis offers a promising avenue for cancer treatment.
Purpose of the Study:
- To identify novel compounds that can induce ferroptosis in liver cancer cells.
- To explore the potential of diazepam derivatives as anticancer agents.
Main Methods:
- Synthesis and characterization of novel diazepam derivatives.
- Assessment of thiol reactivity and GPX4 modification.
- Evaluation of ferroptosis induction in liver cancer cell lines at nanomolar concentrations.
Main Results:
- Identification of irreversible, thiol-reactive diazepam derivatives.
- Demonstration that these derivatives act as GPX4 modifiers.
- Confirmation of nanomolar induction of ferroptosis in liver cancer cells.
Conclusions:
- Novel diazepam derivatives can effectively induce ferroptosis in liver cancer.
- These compounds represent a promising new class of chemotherapeutics targeting GPX4.
More Related Videos
09:00An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
Published on: March 18, 2015
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
